Catheter Precision FY2025 rev +95% to $819K; net loss $17.2M; acquires Flyte aviation platform

Catheter Precision, Inc.

Revenue $819K in FY2025, up 95% from $420K in FY2024; gross margin improved to 92.3% from 90.0%.
Net loss of $17.2M in FY2025, of which $7.8M non-cash, compared to $16.6M net loss in FY2024.
Q4 2025 revenue $238K, up 60% YoY; net loss $5.3M ($3.5M non-cash) vs $5.6M in Q4 2024.
Acquired Flyte, a regional air mobility company, post-year-end; financing completed to support two-platform growth strategy.
CE Mark received for LockeT in April 2025; added 32 new customers across VIVO and LockeT platforms.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Catheter Precision, Inc. reported the quarter and year ended December 31, 2025 results: revenue $819 thousand, net income $17.2 million.

Period: the quarter and year ended December 31, 2025
Revenue: $819 thousand
Net income: $17.2 million
Result: reported results

Exact text from the filing

create a compelling framework for accelerated growth and a potential re-rating as execution milestones are achieved. 2025 Full Year Financial Highlights ● 2025 Revenue of $819 thousand, a 95% increase over 2024 Revenue of $420 thousand. ● 2025 Gross Margin of 92.3% compared with 90.0% in 2024. ● Net Loss of $17.2 million of which $7.8 million was non-cash

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Catheter Precision, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-26-010721

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.